Blepharitis Market is Expected to Expand at a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies – Tarsus Pharmaceuticals, Premark Pharmaceuticals

Blepharitis Market is Expected to Expand at a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies - Tarsus Pharmaceuticals, Premark Pharmaceuticals
DelveInsight Business Research LLP
DelveInsight’s “Blepharitis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Blepharitis, historical and forecasted epidemiology as well as the Blepharitis market trends in the United States, EU4(Germany, Spain, Italy, France, and the United Kingdom) and Japan.

DelveInsight’s Blepharitis Market Insights, Epidemiology, and Market Forecast-2032 report delivers an in-depth understanding of the Blepharitis epidemiology insights,Blepharitis market trends, therapies and key companies working in the Blepharitis market in the 7MM.

Blepharitis Overview

According to the American Optometric Association, Blepharitis is an inflammation of the eyelids in which they become red, irritated, itchy, and dandruff-like scales form on the eyelashes. It is a chronic external eye disorder resulting in red, burning, and irritated eyes which does not cause serious damage to the eyes, but it can be very uncomfortable. It can be caused by either bacteria or a skin condition, such as dandruff of the scalp or rosacea. Blepharitis, on the basis of anatomic location, is of three types: Anterior Blepharitis, Posterior Blepharitis, and Mixed Anterior and Posterior Blepharitis. Anterior Blepharitis affects the front of the eyelids around the eyelashes and may be due to seborrhoeic dermatitis, may also involve the scalp, face, and ears, or be due to bacterial (staphylococcal) infection. Posterior Blepharitis mainly affects the back of the eyelids, around the Meibomian glands, often associated with rosacea. Mixed anterior and posterior blepharitis is a combination of both anterior and posterior blepharitis


Blepharitis Epidemiology Insights

  • In a study by John Meyer (2022), Demodex blepharitis can affect individuals of all ages, its prevalence increases with age, with more than 80% of people who are 60 and 100% of those aged over 70 years.

  • In a study by McCulley et al. (1982), patients who have staphylococcal blepharitis were found to be relatively younger (42 years old) and most were female (80%).

  • In a survey conducted by Duncanet al., (2015), in the United  States, 37%  to  47%  of patients seen by respondents were diagnosed with blepharitis.

  • In a 2009 US survey, 37% of patients seen by an ophthalmologist and 47% of patients seen by an optometrist had signs of blepharitis (NIH).

  • According to the Atlas study (2022), over half of the patients (51%) have experienced signs and symptoms of Demodex blepharitis for more than 4 years, and 58% of patients were never diagnosed with blepharitis.

  • In a study by Lemp et al. (2009), ophthalmologists and optometrists observe blepharitis in 37–47% of their patients.

Click here to learn more about the Blepharitis Market Landscape

The Report Covers the Blepharitis Epidemiology Segmented by:

  • Total Blepharitis prevalent cases 

  • Total Blepharitis type specific prevalent cases 

  • Total Blepharitis diagnosed cases 

  • Total Blepharitis treatable cases 

Blepharitis Market Outlook 

The Blepharitis market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Blepharitis market trends by analyzing the impact of current Blepharitis therapies on the market, unmet needs, drivers and barriers, and demand for better technology.

This segment gives a thorough detail of the Blepharitis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Blepharitis market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Blepharitis market in 7MM is expected to witness a major change in the study period 2019-2032.

Key Companies Working in the Blepharitis Market

  • Tarsus Pharmaceuticals 

  • Premark Pharmaceuticals 

And many others 

Blepharitis Therapies Covered and Analyzed in the Report

  • TP-03

  • PMP2207

And many others 

Learn more about the Key Companies and Emerging Therapies in the Blepharitis Market

Table of Contents 

  1. Key Insights 

  2. Blepharitis  Introduction 

  3. Executive Summary of Blepharitis           

  4. Disease Background and Overview

  5. Epidemiology and patient population

  6. Blepharitis  Emerging Therapies

  7. Blepharitis Market Outlook

  8. Blepharitis Market Access and Reimbursement of Therapies

  9. Blepharitis Market Drivers 

  10. Market Barriers 

  11. Appendix

  12. Report Methodology

  13. DelveInsight Capabilities

  14. Disclaimer

Learn about the detailed offerings of the report @ Blepharitis Market Outlook

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States